Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions
NCT ID: NCT01908166
Last Updated: 2017-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
61 participants
INTERVENTIONAL
2014-01-31
2016-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy
NCT05206942
Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions
NCT01698190
Comparative Diagnostic Yield of Contrast-Enhanced Versus Conventional Ultrasound Guidance for Coaxial Biopsy of Hepatic Lesions
NCT07249268
Innovative Liver Elasticity, Attenuation, and Dispersion Ultrasound Study
NCT04012242
A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver Neoplasms
NCT02413437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To determine the utility of ultrasound elastography in correlation with kidney or liver biopsy or magnetic resonance imaging (MRI) or computed tomography (CT) results.
OUTLINE:
Patients undergo ultrasound elastography.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diagnostic (ultrasound elastography)
Patients undergo ultrasound elastography.
ultrasound elasticity imaging
Undergo ultrasound elastography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound elasticity imaging
Undergo ultrasound elastography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed
* Patients of any ethnic background
* Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria
* No requirements due to co-morbid disease or intercurrent illness, as needed
* No restrictions on allergic reactions as no imaging agent will be used
* Concomitant medications for treatment of the target lesion
* Pregnant or nursing patients will be excluded from the study
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Juergen Willmann
Professor of Radiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juergen Willmann
Role: PRINCIPAL_INVESTIGATOR
Stanford University Hospitals and Clinics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University, School of Medicine
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2013-01353
Identifier Type: REGISTRY
Identifier Source: secondary_id
VAR0099
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.